OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
HSD$52.1560

Hansard Global PLC

Life & Health InsuranceVerified

Hansard Global PLC exhibits a highly leveraged capital structure with a price-to-book ratio of 434.76 and a price-to-tangible-book ratio of 434.76, indicating significant premium valuation relative to its equity base. The company maintains a liquidity position of GBP 51.5 million in cash and equivalents, which is 31.2% of its total assets, suggesting strong short-term liquidity. However, the free cash flow of GBP -3.2 million indicates a negative cash flow from operations after capital expenditures, which may pressure liquidity in the medium term. Profitability metrics show a return on equity of 10.91%, which is relatively high, but the return on assets of 0.13% is significantly low, indicating that the company is not efficiently utilizing its assets to generate returns. The operating income of GBP 16 million and net income of GBP 1.8 million suggest a narrow margin of profitability, which may be sensitive to operational or market fluctuations. The company's revenue is concentrated in a single business model focused on life assurance and related activities, with no disclosed geographic diversification in the provided data. This lack of segment or geographic diversification increases exposure to sector-specific risks. The company's total revenue of GBP 46.6 million is derived from its core insurance operations, with no material revenue from other business lines. Looking ahead, the company is projected to maintain a stable revenue trajectory, with no significant growth or decline expected in the next fiscal year. The current fiscal year revenue of GBP 46.6 million is expected to remain relatively flat, with no disclosed growth initiatives or market expansion plans. The company's operating income of GBP 16 million is also expected to remain stable, with no material changes in cost structure or revenue drivers anticipated. The risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. The company's debt-to-equity ratio of 0.16 suggests a conservative capital structure, with minimal leverage exposure. The absence of dilution risk is supported by the fact that the number of shares outstanding has not changed between basic and diluted shares, indicating no imminent equity issuance. Recent events include a strong analyst consensus with a mean price target of GBP 65.00 and a mean recommendation of 1.00 (strong buy), indicating positive sentiment among analysts. The company has not disclosed any material recent filings or transcripts that would suggest operational or strategic changes.

30-day price · HSD+5.89 (+12.3%)
Low$46.00High$54.00Close$53.89As of10 May, 00:00 UTC
Profile
CompanyHansard Global PLC
TickerHSD.L
SectorFinancials
BusinessInsurance
Industry groupInsurance
IndustryLife & Health Insurance
AI analysis

Business. Hansard Global PLC provides long-term savings and investment solutions through life assurance wrappers for international clients, operating via subsidiaries including Hansard International Limited and Hansard Europe Designated Activity Company.

Classification. Hansard Global PLC is classified in the Financials sector under the Life & Health Insurance industry with a confidence level of 0.92.

Hansard Global PLC exhibits a highly leveraged capital structure with a price-to-book ratio of 434.76 and a price-to-tangible-book ratio of 434.76, indicating significant premium valuation relative to its equity base. The company maintains a liquidity position of GBP 51.5 million in cash and equivalents, which is 31.2% of its total assets, suggesting strong short-term liquidity. However, the free cash flow of GBP -3.2 million indicates a negative cash flow from operations after capital expenditures, which may pressure liquidity in the medium term. Profitability metrics show a return on equity of 10.91%, which is relatively high, but the return on assets of 0.13% is significantly low, indicating that the company is not efficiently utilizing its assets to generate returns. The operating income of GBP 16 million and net income of GBP 1.8 million suggest a narrow margin of profitability, which may be sensitive to operational or market fluctuations. The company's revenue is concentrated in a single business model focused on life assurance and related activities, with no disclosed geographic diversification in the provided data. This lack of segment or geographic diversification increases exposure to sector-specific risks. The company's total revenue of GBP 46.6 million is derived from its core insurance operations, with no material revenue from other business lines. Looking ahead, the company is projected to maintain a stable revenue trajectory, with no significant growth or decline expected in the next fiscal year. The current fiscal year revenue of GBP 46.6 million is expected to remain relatively flat, with no disclosed growth initiatives or market expansion plans. The company's operating income of GBP 16 million is also expected to remain stable, with no material changes in cost structure or revenue drivers anticipated. The risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. The company's debt-to-equity ratio of 0.16 suggests a conservative capital structure, with minimal leverage exposure. The absence of dilution risk is supported by the fact that the number of shares outstanding has not changed between basic and diluted shares, indicating no imminent equity issuance. Recent events include a strong analyst consensus with a mean price target of GBP 65.00 and a mean recommendation of 1.00 (strong buy), indicating positive sentiment among analysts. The company has not disclosed any material recent filings or transcripts that would suggest operational or strategic changes.
Key takeaways
  • Hansard Global PLC is a life assurance provider with a high price-to-book ratio and low asset efficiency.
  • The company maintains strong liquidity but faces challenges with free cash flow generation.
  • Analysts are bullish, with a strong buy rating and a mean price target of GBP 65.00.
  • The company's revenue is concentrated in a single business model with no geographic diversification.
  • The capital structure is conservative, with low debt-to-equity and no immediate dilution risk.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyGBP
Revenue$46.6M
Gross profit
Operating income$16.0M
Net income$1.8M
R&D
SG&A
D&A
SBC
Operating cash flow$13.9M
CapEx-$1.0M
Free cash flow-$3.2M
Total assets$1.35B
Total liabilities$1.33B
Total equity$16.5M
Cash & equivalents$51.5M
Long-term debt$2.7M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$52.15
Market cap$7.17B
Enterprise value$7.12B
P/E3985.3
Reported non-GAAP P/E
EV/Revenue152.9
EV/Op income445.3
EV/OCF512.6
P/B434.8
P/Tangible book434.8
Tangible book$16.5M
Net cash$48.8M
Current ratio
Debt/Equity0.2
ROA0.1%
ROE10.9%
Cash conversion7.7%
CapEx/Revenue-2.1%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Life & Health Insurance · cohort 1 companies
MetricHSDActivity
Op margin34.3%21.1% medp25 16.7% · p75 136.5%above median
Net margin3.9%10.4% medp25 5.7% · p75 19.8%bottom quartile
Gross margin21.0% medp25 21.0% · p75 21.0%
CapEx / revenue-2.1%2.4% medp25 2.4% · p75 2.4%bottom quartile
Debt / equity16.0%48.5% medp25 43.7% · p75 53.3%bottom quartile
Observations
IR observations
Mean price target65.00 GBP
Median price target65.00 GBP
High price target65.00 GBP
Low price target65.00 GBP
Mean recommendation1.00 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count0.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.03 GBP
Last actual EPS0.01 GBP
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 09:02 UTC#5010e76c
Market quoteclose GBP 52.15 · shares 0.14B diluted
no public URL
2026-05-10 09:02 UTC#81a83c1f
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 09:04 UTCJob: 477a7f90